Flow Cytometric Analysis of In Vitro Proinflammatory Cytokine Secretion in Peripheral Blood from Multiple Sclerosis Patients

The cytokines, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-αrpar;, and interleukin-2 (IL-2) are important endogenous proinflammatory proteins and have been linked to disease activity in multiple sclerosis. In this study, we use flow cytometric methodology to compare the secretion of IFN-γ, IL-2, and TNF-α from peripheral blood-derived T cells of multiple sclerosis patients to the secretion in healthy controls. The percentages of IFN-γ, IL-2, and TNF-α secreting cells are not significantly different between multiple sclerosis patients and controls. However, the TNF-α secreting CDS cell percentage is correlated with the IFN-γ and IL-2 secreting CD3 cell percentages in multiple sclerosis patients. In the controls, only the TNF-α secreting CD3 cell percentage is correlated with IFN-γ. These findings show that correlated secretion of cytokines occurs in multiple sclerosis and suggest that concerted intercytokine interactions may play an important role in the disease.

[1]  R. Hohlfeld,et al.  Differential aspects of cytokines in the immunopathology of multiple sclerosis. , 1995, Neurology.

[2]  R. Hirsch,et al.  Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro , 1985, Journal of Clinical Immunology.

[3]  K. Murphy,et al.  Heterogeneity of single cell cytokine gene expression in clonal T cell populations , 1994, The Journal of experimental medicine.

[4]  U. Andersson,et al.  Enumeration of IFN-gamma-producing cells by flow cytometry. Comparison with fluorescence microscopy. , 1988, Journal of immunological methods.

[5]  L. Weiner,et al.  Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. , 1995, Journal of immunology.

[6]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[7]  M. Jensen,et al.  Interferon γ- and interleukin-4-secreting cells in multiple sclerosis , 1993, Journal of Neuroimmunology.

[8]  P. Lebon,et al.  Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions , 1988, Journal of the Neurological Sciences.

[9]  D. Belin,et al.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors , 1986, The Journal of experimental medicine.

[10]  H. Friedman,et al.  Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis , 1996, Clinical and diagnostic laboratory immunology.

[11]  D. Metcalfe,et al.  Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. , 1995, Journal of immunological methods.

[12]  R. Hirsch,et al.  EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.

[13]  M. Jensen,et al.  Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b , 1995, Neurology.

[14]  M. Jensen,et al.  Interferon β decreases T cell activation and interferon γ production in multiple sclerosis , 1993, Journal of Neuroimmunology.

[15]  J. Philippé,et al.  In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis. , 1996, Clinical neurology and neurosurgery.

[16]  R. Rudick,et al.  In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis , 1998, Neurology.

[17]  M. Jensen,et al.  Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. , 1993, Journal of neuroimmunology.

[18]  J. Philippé,et al.  In vitro TNF-α, IL-2 and IFN-γ production as markers of relapses in multiple sclerosis , 1996, Clinical Neurology and Neurosurgery.

[19]  E. Benveniste,et al.  Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes , 1989, Journal of Neuroimmunology.

[20]  M. Jensen,et al.  Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. , 1993, Journal of neuroimmunology.

[21]  U. Andersson,et al.  Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. , 1992, Immunology.

[22]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[23]  D. Liggitt,et al.  Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon. , 1989, Pathology and immunopathology research.

[24]  R. P. Kinkel,et al.  Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis , 1997, Neurology.

[25]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[26]  K. Wessel,et al.  Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis , 1997, Journal of the Neurological Sciences.

[27]  E. Reinherz,et al.  Multiple sclerosis: distribution of T cell subsets within active chronic lesions. , 1983, Science.

[28]  H. Friedman,et al.  Alterations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients , 1995, Clinical and diagnostic laboratory immunology.

[29]  Neil Salkind,et al.  Using SPSS for Windows: Analyzing and Understanding Data with Disk , 1997 .

[30]  J. Trotter,et al.  Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels , 1991, Journal of Neuroimmunology.

[31]  R. Hohlfeld,et al.  Different aspects of cytokines in the immunopathology of multiple scleroosis , 1995, Neurology.